Why GSK stock is a low performer

Discussion in 'GlaxoSmithKline' started by anonymous, Aug 27, 2016 at 3:47 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Products produced by HR that are crap
    Senior management that doesn't have a clue ....
    Employees trapped in a toxic culture
    Representatives that can't sell because of the CIA agreement ...... And a
    Payer division that only know how to contract by offering deep discounts

    Shall I go on --

    Next year you can expect two important events; 1) sharp decline in sales caused by generics and 2) election of one two idiots running for president that will adversely affect pharma financially.

    I am tired of holding this stock. Good bye GSK
     

  2. sirandy

    sirandy new user

    Joined:
    Feb 13, 2016
    Messages:
    111
    Likes Received:
    1

    Plus, company only has one Dingo. If we had hundreds more, our stock might break 46 before I die.
     
  3. anonymous

    anonymous Guest

    socialist leadership with an empty pipeline and looming patent cliff. Without dingos financial wizardry the stock would be at $5 bucks!

    Forward!
     
  4. anonymous

    anonymous Guest

    If you substituted "socialist" with "unfettered capitalist" you would have an equally valid explanation of why we are where we are. In the US we have a history of boom and bust, of vacillating from one extreme to the other. Moderates have a tough time getting through the cacophony of shrill voices and easy-to-comprehend thoughts coming from the extremes.
     
  5. anonymous

    anonymous Guest

    Boom? Not so much, more like a steady decline.

    Central control by an unaccountable dopes, who fail over and over while getting rich along the way. Maybe crony capitalism.
     
  6. anonymous

    anonymous Guest

    Spot on.